You need to enable JavaScript to run this app.
Recon: CDC recommends Pfizer booster for 12- to 15-year-olds; Stryker to buy Vocera for nearly $3B
Recon
Joanne S. Eglovitch
Biologics
Biotechnology
Diagnostics
Global
Medical Devices
North America
Pharmaceuticals
Regulatory Intelligence/Policy